Annovis Bio, Inc.
NYSE:ANVS
4.37 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 2.69 | 5.785 | 6.515 | 8.905 | 13.838 | 8.262 | 7.786 | 1.577 | 5.313 | 6.816 | 2.81 | 2.884 | 1.381 | 1.825 | 2.39 | 1.412 | 0.719 | 0.856 | 0.066 | 0.762 | 0.002 | 0.006 | 0.006 | 0.013 | 0.013 | 0.027 | 0.058 |
| General & Administrative Expenses
| 1,698.05 | 1.977 | 1.295 | 1.538 | 1.026 | 1.498 | 2.184 | 1.592 | 2.361 | 1.938 | 3.104 | 3.036 | 1.473 | 0.71 | 0.84 | 0.497 | 0.885 | 1.687 | 0.517 | 0.109 | 0.24 | 0.3 | 0.181 | 0.155 | 0.124 | 0.191 | 0.132 |
| Selling & Marketing Expenses
| -1,696.352 | -1,975.444 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 1.698 | 1.977 | 1.295 | 1.538 | 1.026 | 1.498 | 2.184 | 1.592 | 2.361 | 1.938 | 3.104 | 3.036 | 1.473 | 0.71 | 0.84 | 0.497 | 0.885 | 1.687 | 0.517 | 0.109 | 0.24 | 0.3 | 0.181 | 0.155 | 0.124 | 0.191 | 0.132 |
| Other Expenses
| 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.037 | 0 | -0.007 | -0.029 | -0.205 | -0.587 | -0.208 | -0.157 | -0.735 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 4.388 | 7.763 | 7.81 | 10.442 | 14.863 | 9.76 | 9.97 | 3.169 | 7.674 | 8.754 | 5.914 | 5.92 | 2.854 | 2.527 | 3.2 | 1.705 | 1.017 | 2.335 | 0.426 | 0.136 | 0.242 | 0.306 | 0.187 | 0.168 | 0.138 | 0.218 | 0.19 |
| Operating Income
| -4.388 | -7.763 | -7.81 | -10.442 | -14.717 | -9.76 | 9.97 | -3.169 | -7.674 | -8.754 | -5.875 | -5.92 | -2.854 | -2.534 | -3.229 | -1.91 | -1.604 | -2.544 | -0.583 | -0.871 | -0.242 | -0.306 | -0.187 | -0.168 | -0.138 | -0.218 | -0.19 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -8.251 | 2.742 | 6.743 | -11.771 | 0.147 | 0.223 | 0.233 | 0.074 | 0.053 | 2.818 | -0.02 | 0.005 | 0.006 | 0.01 | 0.03 | 0.205 | 0.597 | 0.234 | 0.142 | 0.67 | -0.012 | -0.039 | -0.004 | 0 | 0 | 0 | 0 |
| Income Before Tax
| -12.638 | -5.02 | -1.067 | -22.213 | -14.717 | -9.537 | -9.737 | -3.095 | -7.621 | -8.718 | -5.894 | -5.915 | -2.848 | -2.525 | -3.2 | -1.705 | -1.006 | -2.309 | -0.442 | -0.201 | -0.254 | -0.345 | -0.191 | -0.168 | -0.138 | -0.218 | -0.19 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0 | -0.01 | 0.132 | -0.01 | 19.707 | -0.074 | -0.106 | -0.072 | -0.039 | -0.011 | -2.854 | -2.527 | -3.2 | -1.705 | -1.017 | -2.335 | -0.168 | -0.723 | -0.242 | 0.012 | -0.187 | -0.168 | -0.138 | -0.218 | -0.19 |
| Net Income
| -12,638.357 | -5.02 | -1.067 | -22.213 | -14.717 | -9.537 | -29.444 | -3.021 | -7.516 | -8.646 | -5.855 | -5.915 | -2.848 | -2.525 | -3.2 | -1.705 | -1.006 | -2.309 | -0.442 | -0.201 | -0.254 | -0.345 | -0.191 | -0.168 | -0.138 | -0.218 | -0.19 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -973.99 | -0.44 | -0.1 | -2.33 | -1.63 | -1.07 | -3.59 | -0.37 | -0.92 | -1.06 | -0.72 | -0.73 | -0.35 | -0.34 | -0.46 | -0.25 | -0.15 | -0.34 | -0.096 | -0.044 | -0.058 | -0.078 | -0.043 | -0.038 | -0.031 | -0.05 | -0.043 |
| EPS Diluted
| -973.99 | -0.44 | -0.1 | -2.33 | -1.63 | -1.07 | -3.59 | -0.37 | -0.92 | -1.06 | -0.72 | -0.73 | -0.35 | -0.34 | -0.46 | -0.25 | -0.15 | -0.34 | -0.096 | -0.044 | -0.058 | -0.078 | -0.043 | -0.038 | -0.031 | -0.05 | -0.043 |
| EBITDA
| -4.388 | -7.763 | -7.81 | -10.442 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.587 | 0 | 0 | 0.735 | -0.242 | 0 | -0.187 | 0 | 0 | 0 | 0 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |